Recent News

• 08.07.2025 - Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights
• 07.22.2025 - Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
• 06.02.2025 - Sutro Biopharma Appoints Greg Chow as Chief Financial Officer

Recent Filings

• 07.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.30.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.25.2025 - 8-K Current report
• 06.10.2025 - 8-K Current report
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities